LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients
Conditions
End-stage Heart Failure
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Besançon, Besançon, France
Contact: Study coordinator (MARIE FRANCE SERONDE, Pr)Contact: Principal Investigator (MARIE FRANCE SERONDE, Pr)Hôpital Pneumologique et Cardiovasculaire Louis Pradel, Bron, France
CHU Caen, Caen, France
Contact: Study coordinator (KATRIEN DR BLANCHART, Dr)Contact: Principal Investigator (KATRIEN DR BLANCHART, Dr)La Tronche Hospital / CHU Grenoble, La Tronche, France
Contact: Principal Investigator (AUDE BOIGNARD, Dr)Arnaud de Villeneuve Hospital / CHU Montpellier, Montpellier, France
Contact: Principal Investigator (PASCAL BAPTISTELLA, Dr)CHU Rouen, Rouen, France
Contact: Study coordinator (FABRICE BAUER)Contact: Principal Investigator (FABRICE BAUER)CHU Tours, Tours, France
Contact: Study coordinator (Thierry BOURGUIGNON, Dr)Contact: Principal Investigator (Thierry BOURGUIGNON)CHRU, Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu, Vandœuvre-lès-Nancy, France
Contact: Principal Investigator (GUILLAUME BAUDRY, Dr)
Study leads
Guillaume BAUDRY, Dr
Principal Investigator
CHRU Nancy